Registered Rwanda · Rwanda FDA

PILORECT

Haemorrhoidal Suppositories BP

Rwanda FDA-HMP-MA-1902 Suppositories 0.25%w/w ,3.00%w/w ,5.00%w/w .0.50%w/w

What it does

Haemorrhoidal treatments are used to relieve the discomfort caused by swollen veins in the rectum and anus, known as haemorrhoids.

Commonly used for: haemorrhoids (piles)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
Rwanda FDA-HMP-MA-1902
Registration date
17/08/2024
Expiry date
16/08/2029
Status
Registered
Active ingredient
Haemorrhoidal Suppositories BP
Dosage form
Suppositories
Strength
0.25%w/w ,3.00%w/w ,5.00%w/w .0.50%w/w
Pack size
2 blisters x 5 suppositories
Therapeutic class
-
Manufacturer / MAH
Meridian Enterprises
Applicant / LTR
Meridian Enterprises Pvt. Ltd.
Country of origin
INDIA
Manufacturer location
Embassy Centre, 1108, Jamnalal Bajaj Marg, Nariman Point, Mumbai, Maharashtra 400021, India

Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:09 · updated 2026-09-17 02:30:43

Disclaimer: This information is sourced from Rwanda Food and Drugs Authority (Rwanda). Always consult a qualified healthcare professional before using any medication.

About this medicine

Haemorrhoidal treatments are used to relieve the discomfort caused by swollen veins in the rectum and anus, known as haemorrhoids.

What it treats

  • haemorrhoids (piles)

How it works

These treatments help reduce swelling, relieve pain, and soothe irritation in the affected area.

Who it's for

These treatments are suitable for adults experiencing symptoms of haemorrhoids.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: haemorrhoidal

Haemorrhoids, also known as piles, are swollen and inflamed veins in the rectum and anus that cause discomfort, pain, and bleeding. Treatment typically involves topical agents that relieve symptoms such as pain, itching, and inflammation. Common options include local anesthetics, anti-inflammatory agents, and astringents.

Indications

  • Anal itching
  • Pain associated with haemorrhoids
  • Swelling in the anal region
  • Bleeding due to haemorrhoids

Dosage

Children: Refer to specific product guidelines for dosing, as it varies by formulation and should be determined by a healthcare professional.

Adults: Refer to specific product guidelines for dosing, as it varies by formulation and severity of symptoms.

Mechanism of action

Topical treatments for haemorrhoids generally work by providing local relief from symptoms. Local anesthetics block nerve signals in the area, reducing pain. Astringents help to shrink swollen tissues, while anti-inflammatory agents reduce redness and swelling. These mechanisms help alleviate discomfort associated with haemorrhoids.

Pharmacodynamics

The pharmacodynamic effects of treatments for haemorrhoids are primarily localized. Local anesthetics provide rapid relief of pain, while astringents like witch hazel promote tissue contraction and reduce bleeding. Anti-inflammatory agents, such as hydrocortisone, diminish inflammation and suppress the immune response in the affected area, providing symptomatic relief.

Pharmacokinetics

Topical agents for haemorrhoidal treatment exhibit minimal systemic absorption, as they are applied directly to the affected area. The onset of action varies by formulation; local anesthetics typically provide immediate relief, whereas anti-inflammatory effects may take longer to manifest. The duration of action also varies depending on the specific agent used.

Adverse effects

  • Burning sensation
  • Itching
  • Irritation at application site
  • Allergic reactions

Precautions

  • Use with caution in patients with pre-existing anal conditions
  • Avoid use if there is a known hypersensitivity to any of the ingredients
  • Consult a healthcare provider if symptoms persist or worsen

Pregnancy

Consult a healthcare provider before use. Safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare provider before use. Safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Creams
  • Ointments
  • Suppositories
PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.

Kenya 1 product